Belle da Costa Greene, who was JP Morgan’s librarian, became a lively fixture at Gilded Age mansions, country retreats, ...

From volatility and geopolitics to economic trends and investment outlooks, stay informed on the key developments shaping today's markets. Whether it’s hardware, software or age-old businesses, ...

Standard BioTools CEO Michael Egholm said the firm has "reached a tipping point" for its SomaScan proteomics technology, calling it the "crown jewel" of its product portfolio. More than 1,000 studies ...

With 1:06 remaining in the second half of a close Big South Conference game at Radford on Wednesday night, a young fan broke loose onto the floor and sprinted nearly the length of the court ...

Jan 16 (Reuters) - Morgan Stanley's (MS.N), opens new tab profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove its revenue to a full-year record.

Everything we do at Morgan Stanley is guided by our five core values: Do the right thing, put clients first, lead with exceptional ideas, commit to diversity and inclusion, and give back. Morgan ...

Idorsia Ltd (SIX: IDIA) today announced that André C. Muller, Chief Executive Officer of Idorsia, will present at the J.P. Morgan Healthcare Conference on January 15, 2025, at 15:00 PST / 00:00 CET.

Morgan Stanley has promoted Lily Mahdavi and Ben Teasdale to co-lead its mergers and acquisitions team in the Americas, according to a person familiar with the situation. Mahdavi and Teasdale have ...

SAN JOSE, Calif.--(BUSINESS WIRE)--Takara Bio USA Holdings, Inc. (“TBUSH”) today announced the acquisition of Curio Bioscience, a pioneering company in the field of spatial genomics.

INCHEON, South Korea, Jan. 14, 2025 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its latest business ...

Copyright 2025 The Associated Press. All Rights Reserved. Rachel Lerman wears two bracelets supporting Sen. Barack Obama’s candidacy for President, at her home in ...

Darovasertib, a potential first-in-class Phase 2/3 PKC inhibitor program targeting Metastatic Uveal Melanoma (MUM) and Uveal Melanoma (UM) Median progression free survival readout for potential Phase ...